Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
API
81 Articles Available
1
4
Can't find what you're looking for? Try our
advanced search
.
Small Molecule API
Supporting Client Projects for CDMO Success
PAP-Q1-2019-CL-030
3D Printing
Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs
PAO-M12-17-NI-018
CDMO
Alcami to Manufacture Darinaparsin
PAO-M11-17-NI-016
API
Right-First-Time Innovation Approach Drives Continual Investment
PAP-Q4-17-CL-003
API
Achieving Efficient Pharmaceutical Synthesis with Process Intensification
PAP-Q4-17-CL-003
API
Becoming Bioavailable
MCO-M07-17-NI-021
API
Cambrex Invests in New Highly Potent API Manufacturing Capacity
PAO-M08-17-NI-016
Biologics
Propagating a Full Spectrum of Services for ADC Development and Manufacture
PAP-Q2-17-CL-007
API
Optimizing API Production as a True Manufacturing Partner
PAP-Q2-17-CL-009
API
Small Molecule Injectable Manufacturing: Challenges and Complexities
PAP-Q2-17-CL-013
Innovation
Flow Chemistry: Pathway for Continuous API Manufacturing
SCM-M05-NI-023
Innovation
Pharma’s Great Automation Migration
PMP-M05-17-NI-001
API
Connecting the Dots for Clients
PTV-M03-17-IN-009
Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization
POP-M03-17-NI-001
MicroJet Reactor (MJR) for APIs
PTV-M11-16-AP-028
Filling a Market Need
PTV-M11-16-AP-016
Energizing Client Portfolios with Patient-Friendly Dosage Forms
PAP-Q1-17-CL-001
Continuous Manufacturing: To Be Continued…
PAP-Q1-17-VP-001
Changes in the Wind for the CDMO Market
PAP-Q1-17-FA-002
Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions
PAP-Q1-17-CL-006
Q: What will be the Impact of the Requirements that Drug Manufacturers Gain a Similar Level of Supply Chain Understanding for Excipients as they Must Have for APIs?
PAP-Q1-17-RT-005
Particle Engineering for Improved Bioavailability in Oral Solid Dose Medications
PAP-Q1-17-CL-014
Next-Generation OSD Manufacturing Strategy
PAP-Q1-17-CL-015
Innovation and Partnership Through Experience and Acquisition
PAP-Q1-17-CL-013
1
4
»
